ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00B3ZW0K18
Stock Name / FundiShares S&P 500 EUR Hedged UCITS ETF (Acc)
IssuerBlackrock
Entity holding fund iShares V Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF TickerIBCF(EUR) F
ETF TickerIUES.AS(EUR) CXE
ETF TickerIUSE.L(EUR) CXE
ETF TickerIUSE.MI(EUR) CXE
ETF TickerIUSEz(EUR) CXE
ETF TickerIUSE(EUR) ETF Plus

Holdings detail for REGN

Stock NameRegeneron Pharmaceuticals Inc
TickerREGN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS75886F1075
LEI549300RCBFWIRX3HYQ56

Show aggregate REGN holdings

News associated with REGN

Regeneron And Sanofi : CHMP Recommends EU Approval Of Dupixent For Chronic Spontaneous Urticaria
(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending the approval of Dupixent (dupilumab) in the European Union for treating c - 2025-09-22 02:12:20
Peek Under The Hood: JEPQ Has 10% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-08 08:26:56
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Brokerages
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-six analysts that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, sixteen have assigned a buy rating and three […] - 2025-08-26 02:16:48
LABU, INCY, UTHR, REGN: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Regeneron Pharmaceuticals (NASDAQ:REGN) versus Cadrenal Therapeutics (NASDAQ:CVKD) Head-To-Head Analysis
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings. Volatility and Risk Regeneron Pharmaceuticals has a beta […] - 2025-08-20 02:22:48
Truist Financial Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $812.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target reduced by Truist Financial from $940.00 to $812.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of several other reports. The Goldman Sachs Group dropped their price target on […] - 2025-08-14 03:00:52
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Raised by Blair William & Co. IL
Blair William & Co. IL lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.2% in the 1st quarter, Holdings Channel reports. The fund owned 1,282 shares of the biopharmaceutical company’s stock after buying an additional 27 shares during the period. Blair William & Co. IL’s holdings in Regeneron Pharmaceuticals were worth […] - 2025-08-11 06:26:50
Harbour Investments Inc. Sells 32 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Harbour Investments Inc. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 403 shares of the biopharmaceutical company’s stock after selling 32 shares during the quarter. Harbour Investments Inc.’s holdings in […] - 2025-08-07 09:40:47
We Did The Math SPYX Can Go To $58
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:58:54
409 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Purchased by Arkadios Wealth Advisors
Arkadios Wealth Advisors purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 409 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. Several other institutional investors and hedge funds also […] - 2025-08-07 05:38:53
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Expected to Rise, BMO Capital Markets Analyst Says
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target upped by stock analysts at BMO Capital Markets from $600.00 to $640.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price target indicates a potential upside of 12.30% from […] - 2025-08-06 03:12:48
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $828.86 Consensus Target Price from Brokerages
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-four ratings firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, fifteen have assigned a buy recommendation and two […] - 2025-08-04 02:59:01
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 19:31:54
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:40:40
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:35:36
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:02:25
Nasdaq 100 Movers: MRVL, REGN
In early trading on Friday, shares of Regeneron Pharmaceuticals, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.6%. Year to date, Regeneron Pharmaceuticals, has lost about 20.7% of its value. And the worst performing Nasdaq 100 co - 2025-08-01 11:30:09
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Choreo LLC
Choreo LLC boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,746 shares of the biopharmaceutical company’s stock after acquiring an additional 32 shares during the period. Choreo LLC’s holdings in Regeneron Pharmaceuticals […] - 2025-07-24 07:22:56
Crestwood Advisors Group LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Crestwood Advisors Group LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 467 shares of the biopharmaceutical company’s stock after purchasing an additional 25 shares during the quarter. Crestwood Advisors Group […] - 2025-07-24 05:47:12
Kestra Private Wealth Services LLC Has $1.31 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Kestra Private Wealth Services LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,058 shares of the biopharmaceutical company’s stock after buying an additional 132 shares during the quarter. […] - 2025-07-23 07:50:58
Larson Financial Group LLC Has $34,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Larson Financial Group LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 34.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53 shares of the biopharmaceutical company’s stock after selling 28 shares during the quarter. Larson […] - 2025-07-23 06:30:53
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Alps Advisors Inc.
Alps Advisors Inc. raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 71.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 530 shares of the biopharmaceutical company’s stock after purchasing an additional 220 shares during the quarter. Alps Advisors Inc.’s […] - 2025-07-17 05:50:54
Stratos Wealth Partners LTD. Sells 115 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Stratos Wealth Partners LTD. trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 506 shares of the biopharmaceutical company’s stock after selling 115 shares during the period. Stratos Wealth Partners […] - 2025-07-16 04:58:54
Allworth Financial LP Reduces Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Allworth Financial LP trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 821 shares of the biopharmaceutical company’s stock after selling 137 shares during the period. Allworth Financial […] - 2025-07-15 08:20:00
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $584.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by UBS Group from $560.00 to $584.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on REGN. BMO Capital Markets reduced their price objective on Regeneron […] - 2025-07-14 03:30:48
Brown Advisory Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Brown Advisory Inc. lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,269 shares of the biopharmaceutical company’s stock after selling 247 shares during the quarter. Brown Advisory Inc.’s […] - 2025-07-13 05:54:54
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Cut by D.A. Davidson & CO.
D.A. Davidson & CO. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 732 shares of the biopharmaceutical company’s stock after selling 21 shares during the quarter. D.A. […] - 2025-07-11 05:32:52
Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) PT at $813.57
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-five ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have assigned a buy rating and three have issued […] - 2025-07-10 03:07:00
DAVENPORT & Co LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
DAVENPORT & Co LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 427 shares of the biopharmaceutical company’s stock, valued at approximately $271,000. A number of other institutional […] - 2025-07-09 05:11:22
Bessemer Group Inc. Sells 3,860 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Bessemer Group Inc. decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 76.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,218 shares of the biopharmaceutical company’s stock after selling 3,860 shares during the period. Bessemer Group […] - 2025-07-01 05:46:52

iShares S&P 500 EUR Hedged UCITS ETF (Acc) REGN holdings

DateNumber of REGN Shares HeldBase Market Value of REGN SharesLocal Market Value of REGN SharesChange in REGN Shares HeldChange in REGN Base ValueCurrent Price per REGN Share HeldPrevious Price per REGN Share Held
2026-02-02 (Monday)16,226USD 10,389,208REGN holding increased by 276345USD 10,389,2080USD 276,345 USD 640.281 USD 623.251
2026-01-30 (Friday)16,226USD 10,112,863REGN holding decreased by -80702USD 10,112,8630USD -80,702 USD 623.251 USD 628.224
2026-01-29 (Thursday)16,226REGN holding decreased by -24USD 10,193,565REGN holding decreased by -25677USD 10,193,565-24USD -25,677 USD 628.224 USD 628.876
2026-01-28 (Wednesday)16,250REGN holding increased by 24USD 10,219,242REGN holding decreased by -251225USD 10,219,24224USD -251,225 USD 628.876 USD 645.289
2026-01-27 (Tuesday)16,226USD 10,470,467REGN holding increased by 68013USD 10,470,4670USD 68,013 USD 645.289 USD 641.098
2026-01-26 (Monday)16,226REGN holding decreased by -24USD 10,402,454REGN holding decreased by -12334USD 10,402,454-24USD -12,334 USD 641.098 USD 640.91
2026-01-23 (Friday)16,250USD 10,414,788REGN holding decreased by -48448USD 10,414,7880USD -48,448 USD 640.91 USD 643.891
2026-01-22 (Thursday)16,250REGN holding decreased by -24USD 10,463,236REGN holding increased by 42285USD 10,463,236-24USD 42,285 USD 643.891 USD 640.344
2026-01-21 (Wednesday)16,274USD 10,420,951REGN holding increased by 238878USD 10,420,9510USD 238,878 USD 640.344 USD 625.665
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of REGN by Blackrock for IE00B3ZW0K18

Show aggregate share trades of REGN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2026-01-29SELL-24755.730742.885 744.170USD -17,860 589.71 Loss of -3,707 on sale
2026-01-28BUY24766.985747.690 749.620USD 17,991 589.57
2026-01-26SELL-24767.300751.615 753.183USD -18,076 589.18 Loss of -3,936 on sale
2026-01-22SELL-24764.890747.370 749.122USD -17,979 588.79 Loss of -3,848 on sale
2026-01-20BUY23737.870718.380 720.329USD 16,568 588.47
2026-01-16SELL-23749.090726.950 729.164USD -16,771 588.15 Loss of -3,243 on sale
2026-01-15SELL-23756.500738.620 740.408USD -17,029 587.96 Loss of -3,506 on sale
2026-01-12SELL-23811.090765.080 769.681USD -17,703 -
2026-01-09SELL-161821.110790.930 793.948USD -127,826 -
2026-01-08BUY23816.990800.680 802.311USD 18,453 -
2026-01-06BUY23785.405763.195 765.416USD 17,605 -
2026-01-05BUY115771.990753.199 755.078USD 86,834 -
2025-12-30BUY46777.720770.305 771.046USD 35,468 -
2025-12-29BUY46784.990774.595 775.634USD 35,679 -
2025-12-19SELL-23773.850748.180 750.747USD -17,267 -
2025-12-18BUY23752.840739.230 740.591USD 17,034 -
2025-12-17SELL-23751.990743.330 744.196USD -17,117 -
2025-12-16BUY138757.350734.720 736.983USD 101,704 -
2025-12-15BUY46756.660746.375 747.403USD 34,381 -
2025-12-12BUY46746.050734.380 735.547USD 33,835 -
2025-12-11BUY46753.565726.455 729.166USD 33,542 -
2025-12-10BUY46728.000692.500 696.050USD 32,018 -
2025-12-09BUY23711.000691.890 693.801USD 15,957 -
2025-12-02BUY46747.000731.000 732.600USD 33,700 -
2025-12-01BUY115779.840748.210 751.373USD 86,408 -
2025-11-28BUY695788.980779.500 780.448USD 542,411 -
2025-11-24SELL-22773.130756.640 758.289USD -16,682 -
2025-11-21BUY22764.090735.740 738.575USD 16,249 -
2025-11-19SELL-66727.810702.630 705.148USD -46,540 -
2025-11-18SELL-88727.970699.220 702.095USD -61,784 -
2025-11-17SELL-44711.880692.290 694.249USD -30,547 -
2025-11-07SELL-44658.210640.990 642.712USD -28,279 -
2025-11-05SELL-154646.895628.000 629.890USD -97,003 -
2025-10-31SELL-827659.760645.000 646.476USD -534,636 -
2025-10-28BUY24654.480655.700 655.578USD 15,734 -
2025-10-14SELL-144572.600576.180 575.822USD -82,918 -
2025-10-02BUY48600.000605.410 604.869USD 29,034 -
2025-09-30SELL-48562.270574.040 572.863USD -27,497 -
2025-09-16BUY24575.060579.400 578.966USD 13,895 -
2025-09-15BUY24572.590573.690 573.580USD 13,766 -
2025-08-21BUY23598.160605.180 604.478USD 13,903 -
2025-08-20SELL-46591.010596.920 596.329USD -27,431 -
2025-08-13BUY46561.550565.500 565.105USD 25,995 -
2025-08-12BUY23556.550562.740 562.121USD 12,929 -
2025-08-08SELL-23563.000567.690 567.221USD -13,046 -
2025-08-05BUY46569.900579.820 578.828USD 26,626 -
2025-08-04SELL-92571.540577.210 576.643USD -53,051 -
2025-08-01SELL-23558.870583.280 580.839USD -13,359 -
2025-07-31BUY69545.460558.130 556.863USD 38,424 -
2025-07-30BUY23554.580563.590 562.689USD 12,942 -
2025-07-18SELL-69542.520550.890 550.053USD -37,954 -
2025-07-16SELL-46547.930558.350 557.308USD -25,636 -
2025-07-10BUY23559.760566.370 565.709USD 13,011 -
2025-07-07BUY46538.110547.590 546.642USD 25,146 -
2025-07-02BUY23547.740551.500 551.124USD 12,676 -
2025-06-24BUY46522.270527.450 526.932USD 24,239 -
2025-06-23BUY23511.920516.180 515.754USD 11,862 -
2025-06-18BUY23513.580519.170 518.611USD 11,928 -
2025-06-17BUY23508.860523.010 521.595USD 11,997 -
2025-06-05SELL-46483.070491.770 490.900USD -22,581 -
2025-06-03BUY46487.860501.110 499.785USD 22,990 -
2025-05-28BUY253591.850606.000 604.585USD 152,960 -
2025-05-27BUY69603.260608.170 607.679USD 41,930 -
2025-05-22SELL-23596.850605.500 604.635USD -13,907 -
2025-05-21SELL-23604.620617.520 616.230USD -14,173 -
2025-05-20SELL-46614.790615.450 615.384USD -28,308 -
2025-05-19SELL-46596.540598.560 598.358USD -27,524 -
2025-05-15BUY23584.990585.260 585.233USD 13,460 -
2025-05-14BUY46571.360580.560 579.640USD 26,663 -
2025-05-13BUY69574.160575.050 574.961USD 39,672 -
2025-05-12BUY138575.630577.990 577.754USD 79,730 -
2025-05-09BUY69527.780552.840 550.334USD 37,973 -
2025-05-02BUY23605.610615.610 614.610USD 14,136 -
2025-04-30BUY960598.760600.200 600.056USD 576,054 -
2025-04-28BUY22610.860614.830 614.433USD 13,518 -
2025-04-25SELL-22602.640602.790 602.775USD -13,261 -
2025-04-24BUY66599.760601.280 601.128USD 39,674 -
2025-04-23BUY22587.850603.770 602.178USD 13,248 -
2025-04-22BUY22585.490587.100 586.939USD 12,913 -
2025-04-16SELL-22549.280561.830 560.575USD -12,333 -
2025-04-15BUY22557.910575.200 573.471USD 12,616 -
2025-04-14BUY44571.060574.720 574.354USD 25,272 -
2025-04-11BUY44554.180555.530 555.395USD 24,437 -
2025-04-10BUY22546.390571.990 569.430USD 12,527 -
2025-04-09BUY22576.720580.730 580.329USD 12,767 -
2025-04-08BUY44556.810586.030 583.108USD 25,657 -
2025-04-07SELL-22572.780591.540 589.664USD -12,973 -
2025-04-04SELL-132573.450612.990 609.036USD -80,393 -
2025-04-01SELL-44617.000641.240 638.816USD -28,108 -
2025-03-31SELL-44634.230640.720 640.071USD -28,163 -
2025-03-28SELL-44637.360642.970 642.409USD -28,266 -
2025-03-25BUY22634.140662.570 659.727USD 14,514 -
2025-03-21SELL-88658.480661.000 660.748USD -58,146 -
2025-03-20SELL-66662.620674.830 673.609USD -44,458 -
2025-03-18BUY132664.960678.270 676.939USD 89,356 -
2025-03-11SELL-22718.160747.700 744.746USD -16,384 -
2025-03-10SELL-66744.830748.290 747.944USD -49,364 -
2025-03-07SELL-154707.510729.750 727.526USD -112,039 -
2025-03-05SELL-66687.150692.790 692.226USD -45,687 -
2025-03-03SELL-88684.870704.640 702.663USD -61,834 -
2025-02-27SELL-22702.780721.000 719.178USD -15,822 -
2025-02-19BUY22685.660688.670 688.369USD 15,144 -
2025-02-18BUY44680.000689.950 688.955USD 30,314 -
2025-02-13BUY44674.270677.690 677.348USD 29,803 -
2025-02-05SELL-176716.720729.250 727.997USD -128,127 -
2025-02-04BUY22697.050709.980 708.687USD 15,591 -
2025-01-31BUY631672.980688.000 686.498USD 433,180 -
2025-01-29BUY21687.270697.570 696.540USD 14,627 -
2025-01-28BUY21686.330690.300 689.903USD 14,488 -
2025-01-24BUY63675.790693.840 692.035USD 43,598 -
2025-01-23BUY147694.640696.190 696.035USD 102,317 -
2025-01-22BUY105680.030699.880 697.895USD 73,279 -
2025-01-21BUY21687.800692.930 692.417USD 14,541 -
2025-01-16BUY126693.230706.540 705.209USD 88,856 -
2025-01-15BUY21703.430712.600 711.683USD 14,945 -
2025-01-10BUY21696.880724.730 721.945USD 15,161 -
2024-12-10BUY22778.500791.490 790.191USD 17,384 -
2024-12-09BUY88788.000800.990 799.691USD 70,373 -
2024-12-05SELL-44767.900768.020 768.008USD -33,792 -
2024-12-04BUY66754.260756.130 755.943USD 49,892 -
2024-12-03SELL-110749.570770.000 767.957USD -84,475 -
2024-12-02BUY44762.340763.890 763.735USD 33,604 -
2024-11-29SELL-551750.220754.510 754.081USD -415,499 -
2024-11-25BUY46749.510757.860 757.025USD 34,823 -
2024-11-22SELL-23738.000751.400 750.060USD -17,251 -
2024-11-21SELL-23744.500757.560 756.254USD -17,394 -
2024-11-18BUY115762.000762.700 762.630USD 87,702 -
2024-11-12BUY23821.000831.000 830.000USD 19,090 -
2024-11-08BUY161828.420830.730 830.499USD 133,710 -
2024-11-07BUY46824.480832.530 831.725USD 38,259 -
2024-11-06BUY23816.650844.510 841.724USD 19,360 -
2024-10-31SELL-492838.200883.150 878.655USD -432,298 -
2024-10-29BUY24927.330932.380 931.875USD 22,365 -
2024-10-28BUY24928.610943.270 941.804USD 22,603 -
2024-10-25BUY24933.020943.830 942.749USD 22,626 -
2024-10-24BUY24928.900952.020 949.708USD 22,793 -
2024-10-23SELL-48941.390959.600 957.779USD -45,973 -
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of REGN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19208,6591,635312,81266.7%
2025-09-18236,4853,679387,51961.0%
2025-09-17229,191716370,89561.8%
2025-09-16173,632584271,02064.1%
2025-09-15204,491251334,49661.1%
2025-09-12117,50433222,76052.7%
2025-09-11125,4783,137286,51643.8%
2025-09-10195,068481339,88557.4%
2025-09-09129,168994274,52047.1%
2025-09-08250,895396527,06247.6%
2025-09-05170,149290289,56658.8%
2025-09-04188,2272,103360,61952.2%
2025-09-03185,679344438,11142.4%
2025-09-02191,954138476,28840.3%
2025-08-29133,226685236,72656.3%
2025-08-28116,5602,177256,67545.4%
2025-08-27113,719465243,83646.6%
2025-08-26210,376450400,19952.6%
2025-08-25149,13068363,37741.0%
2025-08-22211,8223,244701,77030.2%
2025-08-21257,4923,416446,43957.7%
2025-08-20327,738572559,13358.6%
2025-08-19118,4722,191324,31136.5%
2025-08-18146,282388277,90952.6%
2025-08-15209,9233,375441,75247.5%
2025-08-14157,5693,623429,32736.7%
2025-08-13111,342233362,78630.7%
2025-08-12117,647171310,77537.9%
2025-08-11129,5132,676284,75745.5%
2025-08-08128,5591,038431,84129.8%
2025-08-07166,6481,560352,87747.2%
2025-08-06176,311624397,08944.4%
2025-08-05154,257115353,74443.6%
2025-08-04200,7581,913409,89749.0%
2025-08-01349,7753,745728,72048.0%
2025-07-31222,350476549,34440.5%
2025-07-30106,8391,689231,76146.1%
2025-07-29149,359276292,66751.0%
2025-07-28103,6871,380245,28742.3%
2025-07-25103,783556259,06940.1%
2025-07-24156,9742,397291,67753.8%
2025-07-23168,7341,708355,37247.5%
2025-07-22116,324617304,88038.2%
2025-07-2198,482900250,10739.4%
2025-07-18183,1741,051391,90946.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy